HomeCompareCLLKF vs GBDC

CLLKF vs GBDC: Dividend Comparison 2026

CLLKF yields 98.52% · GBDC yields 11.85%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GBDC wins by $17.11M in total portfolio value· pulled ahead in Year 9
10 years
CLLKF
CLLKF
● Live price
98.52%
Share price
$2.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.67M
Annual income
$1,223,566.39
Full CLLKF calculator →
GBDC
GBDC
● Live price
11.85%
Share price
$12.66
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.78M
Annual income
$16,389,263.41
Full GBDC calculator →

Portfolio growth — CLLKF vs GBDC

📍 GBDC pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCLLKFGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CLLKF + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CLLKF pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CLLKF
Annual income on $10K today (after 15% tax)
$8,374.38/yr
After 10yr DRIP, annual income (after tax)
$1,040,031.43/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.11/yr
After 10yr DRIP, annual income (after tax)
$13,930,873.90/yr
At 15% tax rate, GBDC beats the other by $12,890,842.47/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CLLKF + GBDC for your $10,000?

CLLKF: 50%GBDC: 50%
100% GBDC50/50100% CLLKF
Portfolio after 10yr
$12.22M
Annual income
$8,806,414.89/yr
Blended yield
72.06%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

CLLKF
No analyst data
Altman Z
-2.4
Piotroski
4/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.6% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CLLKF buys
0
GBDC buys
0
No recent congressional trades found for CLLKF or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCLLKFGBDC
Forward yield98.52%11.85%
Annual dividend / share$2.00$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1%
Portfolio after 10y$3.67M$20.78M
Annual income after 10y$1,223,566.39$16,389,263.41
Total dividends collected$3.27M$20.36M
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: CLLKF vs GBDC ($10,000, DRIP)

YearCLLKF PortfolioCLLKF Income/yrGBDC PortfolioGBDC Income/yrGap
1$20,552$9,852.22$12,490$1,790.28+$8.1KCLLKF
2$40,915$18,923.82$16,522$3,157.73+$24.4KCLLKF
3$78,987$35,208.35$23,578$5,898.68+$55.4KCLLKF
4$148,040$63,524.12$37,115$11,886.75+$110.9KCLLKF
5$269,673$111,270.18$66,136$26,423.57+$203.5KCLLKF
6$477,982$189,431.85$137,257$66,491.44+$340.7KCLLKF
7$825,234$313,792.87$341,734$194,868.54+$483.5KCLLKF
8$1,389,320$506,319.41$1,050,788$685,133.02+$338.5KCLLKF
9← crossover$2,283,219$796,647.00$4,099,314$2,974,971.01$1.82MGBDC
10$3,666,611$1,223,566.39$20,775,530$16,389,263.41$17.11MGBDC

CLLKF vs GBDC: Complete Analysis 2026

CLLKFStock

BICO Group AB (publ) operates as a bio convergence company in North America, Europe, Asia, and internationally. It operates through two segments, Laboratory Solutions and Bioautomation. The Laboratory Solutions segment offers 3D bioprinters, hybrid microscopes, single-cell dispensing instruments, and liquid handling instruments, as well as services and related consumables, such as bioinks, reagents, microscope lenses, software, printheads, and 3D reconstructed human tissues for applications in regulatory testing. This segment also offers services in 3D cell culture, 3D tissue imaging, multiplex imaging, and digital pathology to pharmaceutical and biotechnology companies. The Bioautomation segment offers products in precision dispensing and biosensor technology to the industrial customer; and diagnostics automation and advanced robotics solutions for the medical and diagnostic industries. In addition, it offers core industrial ecosystem, tissue engineering, multi-omics, cell line development, and diagnostics solutions. It primarily serves medical, pharmaceutical, and cosmetic industries. The company was formerly known as Cellink AB (publ) and changed its name to BICO Group AB (publ) in August 2021. BICO Group AB (publ) was founded in 2016 and is based in Gothenburg, Sweden.

Full CLLKF Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this CLLKF vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CLLKF vs SCHDCLLKF vs JEPICLLKF vs OCLLKF vs KOCLLKF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.